Lipid Metabolism Practice Questions

Q: Which of the following is a primary ketone body?

Acetoacetate. **Explanation:** Ketone bodies are produced in the liver mitochondria during states of high fatty acid oxidation (e.g., starvation, uncontrolled diabetes). The process, known as ketogenesis, follows a specific enzymatic sequence that determines which ketone body is "primary." **1. Why Acetoacetate is the Correct Answer:** Acetoacetate is termed the **primary ketone body** because it is the first ketone body synthesized in the liver. The pathway involves the condensation of Acetyl-CoA molecules to form HMG-CoA, which is then cleaved by **HMG-CoA lyase** to produce Acetoacetate. All other ketone bodies are derived from this parent molecule. **2. Analysis of Incorrect Options:** * **B. Acetone:** This is a secondary ketone body formed by the **spontaneous (non-enzymatic) decarboxylation** of acetoacetate. It is metabolic waste, cannot be utilized for energy, and is excreted via the lungs (causing "fruity breath"). * **C. Beta-hydroxybutyrate:** This is also a secondary ketone body formed by the **enzymatic reduction** of acetoacetate by the enzyme *β-hydroxybutyrate dehydrogenase*. While it is the most abundant ketone body in the blood during ketosis, it is chemically a derivative of acetoacetate. * **D. All are primary:** Incorrect, as only acetoacetate is the initial product of the ketogenic pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Site of Ketogenesis:** Liver mitochondria (but the liver **cannot** utilize ketones because it lacks the enzyme **Thiophorase/β-ketoacyl-CoA transferase**). * **Rate-limiting enzyme:** HMG-CoA Synthase (Mitochondrial). * **Detection:** The **Rothera’s Test** detects Acetoacetate and Acetone, but **not** Beta-hydroxybutyrate. * **Energy Yield:** Beta-hydroxybutyrate provides more ATP than Acetoacetate because it starts at a more reduced state (NADH is generated during its conversion back to acetoacetate in peripheral tissues).

Q: Which of the following biochemical changes is not indicative of hyperlipidemia type II-A?

HDL increased. ### Explanation **Fredrickson Classification of Hyperlipoproteinemias** is a high-yield topic for NEET-PG. To answer this question, one must understand the specific lipoprotein elevation associated with **Type II-A Hyperlipidemia** (also known as Familial Hypercholesterolemia). #### Why "HDL increased" is the Correct Answer: In Type II-A hyperlipidemia, the primary defect is a **deficiency or dysfunction of LDL receptors**. This leads to a selective elevation of **Low-Density Lipoprotein (LDL)**. High-Density Lipoprotein (HDL) levels are typically normal or may even be slightly decreased in various hyperlipidemias; an *increase* in HDL is not a diagnostic feature of Type II-A. Therefore, it is the "incorrect" clinical finding among the options. #### Analysis of Incorrect Options: * **A. Total cholesterol increased:** Since LDL is rich in cholesterol, its accumulation significantly raises the total serum cholesterol levels (often >300 mg/dL in heterozygotes). * **B. Triglycerides normal:** This is a pathognomonic feature of Type II-A. Unlike Type II-B (which has elevated VLDL), Type II-A involves only LDL elevation, meaning triglyceride levels remain within the reference range. * **C. LDL increased:** This is the hallmark of Type II-A. The lack of functional LDL receptors prevents the clearance of LDL from the plasma. #### Clinical Pearls for NEET-PG: * **Type II-A (Familial Hypercholesterolemia):** Associated with **Tendon Xanthomas** (especially the Achilles tendon) and Xanthelasma. * **Type II-B:** Elevated LDL + VLDL (increased Cholesterol + Triglycerides). * **Type I & V:** Characterized by milky plasma due to high Chylomicrons. * **Type III (Dysbetalipoproteinemia):** Associated with **Palmar Xanthomas** and elevation of IDL (Broad-beta disease).

Q: What is the effect of lipotropic agents on fat metabolism?

Increases the rate of lipid output from the liver. **Explanation:** **Lipotropic agents** are substances required for the normal mobilization of fat from the liver. The correct answer is **B** because these agents facilitate the synthesis of **Very Low-Density Lipoproteins (VLDL)**. Triglycerides synthesized in the liver cannot be exported as free molecules; they must be packaged into VLDL particles. This process requires phospholipids (like lecithin) and apolipoproteins (Apo B-100). Lipotropic agents (e.g., Choline, Methionine, Betaine, and Inositol) provide the building blocks for these phospholipids. By increasing VLDL assembly, they ensure the efficient export (output) of lipids from the liver to peripheral tissues, thereby preventing the pathological accumulation of fat. **Analysis of Incorrect Options:** * **Option A:** Lipotropic agents do not stimulate fatty acid synthesis (lipogenesis); rather, they manage the disposal of existing lipids. * **Options C & D:** These agents do not primarily target the HMG-CoA reductase pathway or the rate of cholesterol synthesis; their main role is the transport and mobilization of triglycerides. **Clinical Pearls for NEET-PG:** * **Fatty Liver (Steatosis):** A deficiency of lipotropic agents leads to an accumulation of triglycerides in hepatocytes because they cannot be exported, resulting in non-alcoholic fatty liver disease (NAFLD). * **Choline & Methionine:** Choline is a precursor for phosphatidylcholine (lecithin). Methionine is a lipotropic agent because it acts as a methyl donor for the synthesis of choline. * **VLDL:** Remember that VLDL is the primary vehicle for transporting endogenous triglycerides from the liver to the extrahepatic tissues.

Q: Which of the following is NOT an essential fatty acid?

Palmitic acid. **Explanation:** **Essential Fatty Acids (EFAs)** are fatty acids that the human body cannot synthesize de novo because humans lack the enzymes (**desaturases**) capable of introducing double bonds beyond the $\Delta^9$ position. Therefore, they must be obtained through the diet. **Why Palmitic Acid is the Correct Answer:** Palmitic acid (C16:0) is a **saturated fatty acid**. It is the primary product of the Fatty Acid Synthase (FAS) complex in the cytoplasm. Since the body can synthesize it from Acetyl-CoA (derived from excess carbohydrates or proteins), it is considered **non-essential**. **Analysis of Incorrect Options:** * **Linoleic acid (C18:2, $\omega$-6):** A true essential fatty acid. It serves as the precursor for arachidonic acid. * **Linolenic acid (C18:3, $\omega$-3):** A true essential fatty acid. It is vital for cardiovascular health and is a precursor for EPA and DHA. * **Arachidonic acid (C20:4, $\omega$-6):** It is considered **semi-essential**. While it can be synthesized from linoleic acid, it becomes essential if linoleic acid is deficient in the diet. In the context of this question, it is categorized with the essential group. **High-Yield Clinical Pearls for NEET-PG:** 1. **Deficiency Manifestations:** EFA deficiency leads to **Phrynoderma** (follicular hyperkeratosis/toad skin), poor wound healing, and hair loss. 2. **The $\Delta^9$ Rule:** Humans possess $\Delta^4, \Delta^5, \Delta^6,$ and $\Delta^9$ desaturases. We cannot introduce double bonds at $\Delta^{12}$ or $\Delta^{15}$, which is why Linoleic ($\Delta^{9,12}$) and Linolenic ($\Delta^{9,12,15}$) acids are essential. 3. **Energy Yield:** Palmitic acid oxidation yields **106 ATP** (net) via the $\beta$-oxidation pathway.

Q: Which of the following is not a steroid?

Relaxin. **Explanation:** The core concept tested here is the biochemical classification of hormones based on their chemical structure. **Why Relaxin is the correct answer:** Relaxin is **not a steroid**; it is a **peptide hormone** belonging to the insulin-like growth factor family. It consists of two peptide chains (A and B) linked by disulfide bridges. Produced primarily by the corpus luteum and placenta, its main physiological role is to relax the pelvic ligaments and soften the cervix during childbirth. Because it is a protein, it acts via G-protein coupled receptors (GPCRs) on the cell surface, unlike steroids which act on intracellular receptors. **Analysis of incorrect options:** All other options are derivatives of **Cholesterol** and contain the characteristic **cyclopentanoperhydrophenanthrene (CPPP) ring** structure: * **Pregnenolone:** The "mother of all steroids," it is the first steroid formed from cholesterol by the action of the enzyme Desmolase (CYP11A1). * **17α Hydroxyprogesterone:** A key intermediate in the adrenal steroidogenesis pathway, specifically in the synthesis of cortisol and androgens. * **Estrone (E1):** A classic steroid hormone and one of the three major naturally occurring estrogens. **High-Yield Clinical Pearls for NEET-PG:** * **Steroid Nucleus:** All steroids have 17 carbon atoms arranged in four rings (A, B, C, D). * **Carbon Counts:** Remember the "21-19-18" rule: Progestogens/Corticoids have 21 carbons, Androgens have 19, and Estrogens have 18. * **Rate-limiting step:** The conversion of Cholesterol to Pregnenolone in the mitochondria is the rate-limiting step of steroidogenesis. * **Relaxin Clinical Use:** It is a marker of luteal function and plays a role in renal hemodynamics during pregnancy.

Q: For which of the following dyslipidemias is hyperchylomicronemia the most characteristic finding?

Triglycerides > 1000 mg/dL. **Explanation:** Hyperchylomicronemia (Fredrickson Type I or V hyperlipoproteinemia) is characterized by a massive accumulation of chylomicrons in the plasma, usually due to a deficiency in **lipoprotein lipase (LPL)** or its cofactor **Apo C-II** [1]. **1. Why Option B is Correct:** Chylomicrons are the primary carriers of dietary (exogenous) triglycerides [2]. Because chylomicrons are approximately 90% triglycerides by weight, their massive accumulation leads to extreme hypertriglyceridemia, typically exceeding **1000 mg/dL**. At these levels, the plasma takes on a "milky" appearance, and patients are at a high risk for **acute pancreatitis**. **2. Why the Other Options are Incorrect:** * **Option A (Palmar plane xanthomas):** These are pathognomonic for **Type III Hyperlipoproteinemia** (Dysbetalipoproteinemia), caused by a defect in Apo E, leading to the accumulation of IDL and chylomicron remnants [1]. * **Option C (Subcutaneous extensor tendon xanthomas):** These are classic findings in **Familial Hypercholesterolemia (Type IIa)**, where LDL levels are severely elevated [1]. * **Option D (Low serum cholesterol):** In hyperchylomicronemia, total cholesterol is usually **elevated** (though not as severely as triglycerides) because chylomicrons contain a small percentage of cholesterol. **Clinical Pearls for NEET-PG:** * **Refrigeration Test:** In Type I hyperlipidemia, leaving the serum overnight at 4°C results in a **creamy layer on top** with a clear infranatant. * **Clinical Triad:** Eruptive xanthomas, hepatosplenomegaly, and Lipemia Retinalis. * **Management:** The primary treatment is a **very low-fat diet** (<15% of total calories); conventional fibrates are often less effective in Type I compared to other hypertriglyceridemias.

Q: In the liver, what are the precursors of ketone bodies?

Free fatty acids. **Explanation:** Ketogenesis occurs primarily in the mitochondrial matrix of hepatocytes. The correct answer is **Free Fatty Acids (FFAs)** because they serve as the primary substrate for this pathway. 1. **Why Free Fatty Acids are correct:** During fasting, starvation, or uncontrolled diabetes, low insulin and high glucagon levels trigger **lipolysis** in adipose tissue. This releases FFAs into the blood, which are taken up by the liver. Inside the mitochondria, FFAs undergo **beta-oxidation** to produce **Acetyl-CoA**. When Acetyl-CoA levels exceed the capacity of the TCA cycle, it is diverted into the HMG-CoA lyase pathway to form ketone bodies (Acetoacetate, 3-Hydroxybutyrate, and Acetone). 2. **Why other options are incorrect:** * **Triacylglycerols (TAGs):** While TAGs are the storage form of lipids, they must first be hydrolyzed into FFAs and glycerol before they can enter the ketogenic pathway. * **Cholesterol & Cholesteryl esters:** These are structural lipids or precursors for steroid hormones and bile acids. They cannot be broken down into Acetyl-CoA for energy or ketone body synthesis in humans. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** HMG-CoA Synthase (Mitochondrial isoform). * **Site of synthesis:** Liver (Mitochondria). * **Site of utilization:** Extrahepatic tissues (Brain, Heart, Skeletal muscle). * **Why the liver cannot use ketones:** It lacks the enzyme **Thiophorase** (Succinyl-CoA:3-ketoacid CoA transferase). * **Ketone bodies in urine:** Detected by **Rothera’s Test** (specifically detects Acetoacetate and Acetone, but not Beta-hydroxybutyrate).

Question 1

Which of the following is a primary ketone body?

Accepted Answer

Acetoacetate

Answer

Acetone

Answer

Beta-hydroxybutyrate

Answer

All are primary ketone bodies

Question 2

Which of the following biochemical changes is not indicative of hyperlipidemia type II-A?

Accepted Answer

HDL increased

Answer

Total cholesterol increased

Answer

Triglycerides normal

Answer

LDL increased

Question 3

Which lipoprotein's receptors on blood cells accept cholesterol?

Accepted Answer

LDL

Answer

HDL

Answer

VLDL

Answer

Chylomicrons

Question 4

Glucocorticoids and NSAIDs are used to treat inflammatory conditions, but they differ in their use for asthma. Which of the following statements most accurately describes the biochemical mechanism underlying this difference?

Accepted Answer

Steroids inhibit the production of all eicosanoids by blocking phospholipase A2, whereas NSAIDs selectively inhibit the production of prostaglandins and thromboxanes by blocking cyclooxygenase.

Answer

NSAIDs inhibit the production of all eicosanoids by blocking cyclooxygenase, whereas steroids selectively inhibit the production of leukotrienes by blocking lipoxygenase.

Answer

NSAIDs inhibit the production of leukotrienes and prostaglandins by blocking lipoxygenase and cyclooxygenase, whereas steroids inhibit the production of thromboxanes and leukotrienes by blocking cyclooxygenase and lipoxygenase.

Answer

Steroids inhibit the production of leukotrienes and prostaglandins by blocking phospholipase A2, whereas NSAIDs inhibit the production of leukotrienes and thromboxanes by blocking lipoxygenase and cyclooxygenase.

Question 5

What is the effect of lipotropic agents on fat metabolism?

Accepted Answer

Increases the rate of lipid output from the liver

Answer

Increases the rate of fatty acid synthesis in the liver

Answer

Increases the rate of cholesterol synthesis in the liver

Answer

Decreases the rate of cholesterol synthesis in the liver

Question 6

Which of the following is NOT an essential fatty acid?

Accepted Answer

Palmitic acid

Answer

Arachidonic acid

Answer

Linoleic acid

Answer

Linolenic acid

Question 7

Which of the following is not a steroid?

Accepted Answer

Relaxin

Answer

17α Hydroxyprogesterone

Answer

Estrone

Answer

Pregnenolone

Question 8

For which of the following dyslipidemias is hyperchylomicronemia the most characteristic finding?

Accepted Answer

Triglycerides > 1000 mg/dL

Answer

Palmar plane xanthomas

Answer

Subcutaneous extensor tendon xanthomas

Answer

Low serum cholesterol

Question 9

Arrange the electrophoretic pattern of serum lipoproteins in sequence, starting from the point of origin.

Accepted Answer

Chylomicron, Beta lipoprotein, Pre-beta lipoprotein, Alpha lipoprotein

Answer

Pre-beta lipoprotein, Beta lipoprotein, Alpha lipoprotein, Chylomicron

Answer

Beta lipoprotein, Alpha lipoprotein, Pre-beta lipoprotein, Chylomicron

Answer

Pre-beta lipoprotein, Alpha lipoprotein, Chylomicron, Beta lipoprotein

Question 10

In the liver, what are the precursors of ketone bodies?

Accepted Answer

Free fatty acids

Answer

Triacylglycerols

Answer

Cholesterol

Answer

Cholesteryl esters

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?